Voyager Therapeutics Q3 EPS $(0.40) Beats $(0.42) Estimate, Sales $4.014M Miss $6.350M Estimate
Benzinga Newsdesk 1 day ago
NewsEarningsEarnings BeatsEarnings Misses
Voyager Therapeutics (NASDAQ:VYGR) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of $(0.42) by 4.76 percent. This is a 14.89 percent increase over losses of $(0.47) per share
Voyager Therapeutics (NASDAQ:VYGR) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of $(0.42) by 4.76 percent. This is a 14.89 percent increase over losses of $(0.47) per share from the same period last year. The company reported quarterly sales of $4.014 million which missed the analyst consensus estimate of $6.350 million by 36.79 percent. This is a 69.97 percent decrease over sales of $13.365 million the same period last year.